The DOI matches its Crossref record; 333 of the 333 references it cites were found in a registry or an index.
The delivery of therapeutic oligonucleotides
Open accessAbstract
The oligonucleotide therapeutics field has seen remarkable progress over the last few years with the approval of the first antisense drug and with promising developments in late stage clinical trials using siRNA or splice switching oligonucleotides. However, effective delivery of oligonucleotides to their intracellular sites of action remains a major issue. This review will describe the biological basis of oligonucleotide delivery including the nature of various tissue barriers and the mechanisms of cellular uptake and intracellular trafficking of oligonucleotides. It will then examine a variety of current approaches for enhancing the delivery of oligonucleotides. This includes molecular scale targeted ligand-oligonucleotide conjugates, lipid- and polymer-based nanoparticles, antibody conjugates and small molecules that improve oligonucleotide delivery. The merits and liabilities of these approaches will be discussed in the context of the underlying basic biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–333 of 333
Cuboplexes: Topologically Active siRNA Delivery
Kim, H., & Leal, C. (2015) · ACS Nano · doi:10.1021/acsnano.5b03902 · Cited by 158
Lipid nanoparticles for short interfering RNA delivery
Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00004-3 · Cited by 158
Lipid sorting and multivesicular endosome biogenesis
Bissig, C., & Gruenberg, J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016816 · Cited by 151
Antibody-Linked Spherical Nucleic Acids for Cellular Targeting
Zhang, K., Hao, L., Hurst, S. J., & Mirkin, C. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja306854d · Cited by 150
Cellular uptake and intracellular trafficking of oligonucleotides
Juliano, R. L., & Carver, K. A. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.005 · Cited by 149
Self-citationYu, X., Guo, C., Fisher, P. B., Subjeck, J. R., & Wang, X. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.004 · Cited by 145
Łabieniec-Watała, M., & Watała, C. W. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24222 · Cited by 143
Cell-penetrating peptides for the delivery of nucleic acids
Lehto, T., Kurrikoff, K., & Langel, Ü. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.689285 · Cited by 143
Structural Biology of Innate Immunity
Yin, Q., Fu, T., Li, J., & Wu, H. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112258 · Cited by 142
Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases
Southwell, A. L., Skotte, N. H., Bennett, C. F., & Hayden, M. R. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.09.001 · Cited by 140
Crooke, S. T. (2004) · Current Molecular Medicine · doi:10.2174/1566524043360375 · Cited by 139
Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell
Lönn, P., & Dowdy, S. F. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1046431 · Cited by 136
Recentin vivoadvances in cell-penetrating peptide-assisted drug delivery
Kurrikoff, K., Gestin, M., & Langel, Ü. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1125879 · Cited by 135
Bai, H., You, Y., Hua, Y., Meng, J., Xue, X., Hou, Z., Zhou, Y., Ma, X., Sang, G., & Luo, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.075 · Cited by 134
Ortiz, A., Killian, J. A., Verkleij, A. J., & Wilschut, J. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77041-4 · Cited by 133
Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis
Alam, M. R., Dixit, V., Kang, H. M., Li, Z., Chen, X. S., Trejo, J., Fisher, M. H., & Juliano, R. L. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn115 · Cited by 133
Self-citationTurner, J. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki142 · Cited by 132
Prakash, T. P., Yu, J., Migawa, M. T., Kinberger, G. A., Wan, W. B., Østergaard, M. E., Carty, R. L., Vasquez, G., Low, A., Chappell, A. E., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01948 · Cited by 132
Aptamer-Targeted DNA Nanostructures for Therapeutic Delivery
Charoenphol, P., & Bermudez, H. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500047b · Cited by 132
The Chemistry and Biology of Oligonucleotide Conjugates
Juliano, R. L., Ming, X., & Nakagawa, O. (2012) · Accounts of Chemical Research · doi:10.1021/ar2002123 · Cited by 129
Self-citationYoung, K. L., Scott, A. W., Hao, L., Mirkin, S. E., Liu, G., & Mirkin, C. A. (2012) · Nano Letters · doi:10.1021/nl3020846 · Cited by 128
Multivalent Cyclic RGD Conjugates for Targeted Delivery of Small Interfering RNA
Alam, M. R., Ming, X., Fisher, M. H., Lackey, J. G., Rajeev, K. G., Manoharan, M., & Juliano, R. L. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200235q · Cited by 127
Self-citationZhang, Y., Schwerbrock, N. M. J., Rogers, A. B., Kim, W. Y., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2013.120 · Cited by 126
Frede, A., Neuhaus, B., Klopfleisch, R., Walker, C., Buer, J., Müller, W., Epple, M., & Westendorf, A. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.021 · Cited by 125
Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
Berezhnoy, A., Castro, I., Levay, A. K., Malek, T. R., & Gilboa, E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69856 · Cited by 123
He, H., Zheng, N., Song, Z., Kim, K. H., Yao, C., Zhang, R., Zhang, C., Huang, Y., Uckun, F. M., Cheng, J., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b05470 · Cited by 121
Dirin, M., & Winkler, J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.774366 · Cited by 120
Nakagawa, O., Ming, X., Huang, L., & Juliano, R. L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102635c · Cited by 120
Self-citationDefined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing
Dohmen, C., Fröhlich, T., Lächelt, U., Röhl, I., Vornlocher, H., Hadwiger, P., & Wagner, E. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2011.10 · Cited by 117
DNA nanotubes as intracellular delivery vehicles in vivo
Sellner, S., Kocabey, S., Nekolla, K., Krombach, F., Liedl, T., & Rehberg, M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.099 · Cited by 116
Efficient and Persistent Splice Switching by Systemically Delivered LNA Oligonucleotides in Mice
Roberts, J., Palma, E., Sazani, P., Ørum, H., Cho, M., & Kole, R. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.017 · Cited by 114
Oligonucleotide Therapeutics: Chemistry, Delivery and Clinical Progress
Sharma, V. K., & Watts, J. K. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.144 · Cited by 112
Poly(amidoamine) dendrimer complexes as a platform for gene delivery
Shcharbin, D., Shakhbazau, A., & Bryszewska, M. J. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.853661 · Cited by 112
TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo
Zhang, Q., Hossain, D. M. S., Nechaev, S., Kozłowska, A. K., Zhang, W., Liu, Y., Kowolik, C. M., Swiderski, P. M., Rossi, J. J., Forman, S. J., et al. (2013) · Blood · doi:10.1182/blood-2012-07-442590 · Cited by 111
Ezzat, K., Aoki, Y., Koo, T., McClorey, G., Benner, L., Coenen-Stass, A. M. L., O’Donovan, L., Lehto, T., Garcia-Guerra, A., Nordin, J. Z., et al. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b00490 · Cited by 109
Jang, M., Kim, J. H., Nam, H. Y., Kwon, I. C., & Ahn, H. J. (2015) · Nature Communications · doi:10.1038/ncomms8930 · Cited by 108
Current Progress on aptamer-targeted Oligonucleotide Therapeutics
Dassie, J. P., & Giangrande, P. H. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.118 · Cited by 107
Attar, N., & Cullen, P. J. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.002 · Cited by 107
Katakowski, J. A., Mukherjee, G., Wilner, S. E., Maier, K. E., Harrison, M. T., DiLorenzo, T. P., Levy, M., & Palliser, D. (2015) · Molecular Therapy · doi:10.1038/mt.2015.175 · Cited by 105
Membrane contact, fusion and hexagonal (HII) transitions in phosphatidylethanolamine liposomes
Allen, T. M., Hong, K., & Papahadjopoulos, D. (1990) · Biochemistry · doi:10.1021/bi00464a013 · Cited by 105
Kendall, G. C., Mokhonova, E. I., Moran, M., Sejbuk, N. E., Wang, D. W., Silva, O., Wang, R. T., Martinez, L., Lu, Q. L., Damoiseaux, R. D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3005054 · Cited by 104
A Chemical View of Oligonucleotides for Exon Skipping and Related Drug Applications
Järver, P., O’Donovan, L., & Gait, M. J. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0454 · Cited by 102
Yang, B., Ming, X., Cao, C., Laing, B. M., Yuan, A., Porter, M. A., Hull-Ryde, E. A., Maddry, J. A., Suto, M. J., Janzen, W. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv060 · Cited by 102
Self-citationZheng, M., Librizzi, D., Kılıç, A., Liu, Y., Renz, H. E., Merkel, O. M., & Kissel, T. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.055 · Cited by 101
Doisneau-Sixou, S. F., Szoka, F. C., Green, G. A., Giusti, B., Zon, G., & Chin, D. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.4.662 · Cited by 100
Principles of membrane tethering and fusion in endosome and lysosome biogenesis
Kümmel, D., & Ungermann, C. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.04.007 · Cited by 100
Versatile Site-Specific Conjugation of Small Molecules to siRNA Using Click Chemistry
Yamada, T., Peng, C. G., Matsuda, S., Addepalli, H., Jayaprakash, K. N., Alam, M. R., Mills, K., Maier, M. A., Charissé, K., Sekine, M., et al. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo101761g · Cited by 99
A Raft-derived, Pak1-regulated Entry Participates in α2β1 Integrin-dependent Sorting to Caveosomes
Karjalainen, M., Kakkonen, E., Upla, P., Paloranta, H., Kankaanpää, P., Liberali, P., Renkema, G. H., Hyypiä, T., Heino, J., & Marjomäki, V. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-10-1094 · Cited by 98
Direct targeting of αvβ3 integrin on tumor cells with a monoclonal antibody, Abegrin™
Mulgrew, K. A., Kinneer, K., Yao, X.-T., Ward, B. K., Damschroder, M. M., Walsh, B., Mao, S.-Y., Gao, C., Kiener, P. A., Coats, S., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0356 · Cited by 96
Retrograde transport of protein toxins through the Golgi apparatus
Sandvig, K., Skotland, T., van Deurs, B., & Klokk, T. I. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1111-z · Cited by 96
Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis
Zhou, H.-F., Yan, H., Pan, H., Hou, K. K., Akk, A. M., Springer, L. E., Hu, Y., Allen, J. S., Wickline, S. A., & Pham, C. T. N. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75673 · Cited by 96
Babu, A., Wang, Q., Muralidharan, R., Shanker, M., Munshi, A., & Ramesh, R. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500259e · Cited by 94
Lorenz, P. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.2.582 · Cited by 94
Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics
Hyeon, L. S., Kang, Y. Y., Jang, H.-E., & Mok, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.009 · Cited by 93
Nanoparticle Delivered VEGF-A siRNA Enhances Photodynamic Therapy for Head and Neck Cancer Treatment
Lecaros, R. L. G., Huang, L., Lee, T.-C., & Hsu, Y. (2015) · Molecular Therapy · doi:10.1038/mt.2015.169 · Cited by 93
Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA
Thi, E. P., Mire, C. E., Ursic-Bedoya, R. J., Geisbert, J. B., Lee, A. C. H., Agans, K. N., Robbins, M., Deer, D. J., Fenton, K. A., MacLachlan, I., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009706 · Cited by 90
Jones, S. K., Lizzio, V. A., & Merkel, O. M. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01189 · Cited by 90
Bioconjugates for targeted delivery of therapeutic oligonucleotides
Ming, X., & Laing, B. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.02.002 · Cited by 88
Haussecker, D., & Kay, M. A. (2015) · Science · doi:10.1126/science.1252967 · Cited by 87
Youn, P., Chen, Y., & Furgeson, D. Y. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400446v · Cited by 86
Juliano, R. L., Carver, K. A., Cao, C., & Ming, X. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.740674 · Cited by 85
Self-citationMing, X., Alam, M. R., Fisher, M. H., Yan, Y., Chen, X. S., & Juliano, R. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq534 · Cited by 85
Self-citationTumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA
Liu, X., Wang, W., Samarsky, D. A., Liu, L., Xu, Q., Zhang, W., Zhu, G., Wu, P., Zuo, X., Deng, H., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku831 · Cited by 84
Retrograde Transport: Two (or More) Roads Diverged in an Endosomal Tree?
Johannes, L., & Wunder, C. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01200.x · Cited by 83
Click-Modified Anandamide siRNA Enables Delivery and Gene Silencing in Neuronal and Immune Cells
Willibald, J., Harder, J., Sparrer, K. M. J., Conzelmann, K., & Carell, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303251f · Cited by 82
Carver, K. A., Ming, X., & Juliano, R. L. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.5 · Cited by 78
Self-citationLipid Mixing and Content Release in Single-Vesicle, SNARE-Driven Fusion Assay with 1–5 ms Resolution
Wang, T., Smith, E. A., Chapman, E. R., & Weisshaar, J. C. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.02.050 · Cited by 77
Cesarone, G., Edupuganti, O. P., Chen, C.-P., & Wickstrom, E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070135v · Cited by 77
Zhou, J., Tiemann, K., Chomchan, P., Alluin, J. V., Swiderski, P. M., Burnett, J., Zhang, X., Forman, S. J., Chen, R., & Rossi, J. J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt125 · Cited by 75
Du, L., Kayalı, R., Bertoni, C., Fike, F. M., Hu, H., Iversen, P. L., & Gatti, R. A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr217 · Cited by 74
Identification of siRNA delivery enhancers by a chemical library screen
Gilleron, J., Paramasivam, P., Zeigerer, A., Querbes, W., Marsico, G., Andree, C., Seifert, S., Amaya, P., Stöter, M., Koteliansky, V., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv762 · Cited by 73
Wheeler, L. A., Vrbanac, V. D., Trifonova, R. T., Brehm, M. A., Gilboa-Geffen, A., Tanno, S., Greiner, D. L., Luster, A. D., Tager, A. M., & Lieberman, J. (2013) · Molecular Therapy · doi:10.1038/mt.2013.77 · Cited by 73
The journey of the organelle: teamwork and regulation in intracellular transport
Barlan, K., Rossow, M. J., & Gelfand, V. I. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.02.018 · Cited by 73
New links between vesicle coats and Rab-mediated vesicle targeting
Angers, C. G., & Merz, A. J. (2010) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2010.07.003 · Cited by 72
Nanocarriers for Delivery of siRNA and Co-Delivery of siRNA and Other Therapeutic Agents
Zhao, J., & Feng, S. (2015) · Nanomedicine · doi:10.2217/nnm.15.61 · Cited by 72
Butler, M., Crooke, R. M., Graham, M. J., Lemonidis, K. M., Lougheed, M., Murray, S. F., Witchell, D. R., Steinbrecher, U. P., & Bennett, C. F. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35317-0 · Cited by 72
Development of Therapeutic Splice-Switching Oligonucleotides
Disterer, P., Kryczka, A., Liu, Y., Badi, Y. E., Wong, J. J., Owen, J. S., & Khoo, B. C. E. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.234 · Cited by 71
Kandimalla, E. R., Bhagat, L., Wang, D., Yu, D. S., Sullivan, T., Monica, N. L., & Agrawal, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt078 · Cited by 71
Phelps, K. J., Morris, A. A., & Beal, P. A. (2011) · ACS Chemical Biology · doi:10.1021/cb200422t · Cited by 71
Thiel, W. H., Thiel, K. W., Flenker, K. S., Bair, T., Dupuy, A. J., McNamara, J. O., Miller, F. J., & Giangrande, P. H. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1538-5_11 · Cited by 69
Self-Assembling DNA Dendrimer for Effective Delivery of Immunostimulatory CpG DNA to Immune Cells
Mohri, K., Kusuki, E., Ohtsuki, S., Takahashi, N., Endo, M., Hidaka, K., Sugiyama, H., Takahashi, Y., Takakura, Y., & Nishikawa, M. (2015) · Biomacromolecules · doi:10.1021/bm501731f · Cited by 69
Glycoclusters on oligonucleotide and PNA scaffolds: synthesis and applications
Spinelli, N., Defrancq, É., & Morvan, F. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35406c · Cited by 67
Shepard, H. M., Jin, P., Slamon, D. J., Pirot, Z., & Maneval, D. C. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-73259-4_9 · Cited by 65
AVI-7288 for Marburg Virus in Nonhuman Primates and Humans
Heald, A. E., Charleston, J. S., Iversen, P. L., Warren, T. K., Saoud, J. B., Al-Ibrahim, M. S., Wells, J., Warfield, K. L., Swenson, D. L., Welch, L. S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410345 · Cited by 63
Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates
Catuogno, S., Rienzo, A., Vito, A. D., Esposito, C. L., & de Franciscis, V. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.276 · Cited by 62
Polymers for Nucleic Acid Transfer—An Overview
Wagner, E. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00008-0 · Cited by 62
Chu, S., Tang, C., & Yin, C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.044 · Cited by 61
Albumin-based nanoconjugates for targeted delivery of therapeutic oligonucleotides
Ming, X., Carver, K. A., & Wu, L. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.066 · Cited by 61
Dynamics of receptor trafficking in tumorigenicity
Parachoniak, C. A., & Park, M. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.02.002 · Cited by 60
Alam, M. R., Ming, X., Dixit, V., Fisher, M. H., Chen, X. S., & Juliano, R. L. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0211 · Cited by 60
Self-citationMultifunctional pH-Sensitive Amino Lipids for siRNA Delivery
Gujrati, M. D., Vaidya, A. M., & Lu, Z. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00538 · Cited by 59
Synthetic SiRNA Delivery: Progress and Prospects
Roberts, T. C., Ezzat, K., Andaloussi, S. E., & Weinberg, M. S. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3112-5_23 · Cited by 59
Advanced morpholino oligomers: A novel approach to antiviral therapy
Warren, T. K., Shurtleff, A. C., & Bavari, S. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.02.004 · Cited by 58
Wagenaar, T. R., Tolstykh, T., Shi, C., Jiang, L., Zhang, J., Li, Z., Yu, Q., Qu, H., Sun, F., Cao, H., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1367 · Cited by 55
Antibody–Drug Conjugate Target Selection: Critical Factors
Bander, N. H. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-541-5_2 · Cited by 54
Smith, B. R., Cheng, Z., De, A., Rosenberg, J., & Gambhir, S. S. (2010) · Small · doi:10.1002/smll.201001022 · Cited by 53
Ming, X., Carver, K. A., FISHER, M. S., Noël, R., Cintrat, J., Gillet, D., Barbier, J., Cao, C., Bauman, J. A., & Juliano, R. L. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt066 · Cited by 52
Self-citationMeissner, J. M., Toporkiewicz, M., Czogalla, A., Matusewicz, L., Kuliczkowski, K., & Sikorski, A. F. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.015 · Cited by 51
Targeted In Vivo Delivery of siRNA and an Endosome-Releasing Agent to Hepatocytes
Sebestyén, M. G., Wong, S. C., Trubetskoy, V. S., Lewis, D. L., & Wooddell, C. I. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1538-5_10 · Cited by 50
‘Smart’ nanoparticles as drug delivery systems for applications in tumor therapy
Fang, Z., Wan, L., Chu, L., Zhang, Y., & Wu, J. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1071352 · Cited by 50
An Amino Acid-based Amphoteric Liposomal Delivery System for Systemic Administration of siRNA
Adami, R. C., Seth, S., Harvie, P., Johns, R. E., Fam, R., Fosnaugh, K. L., Zhu, T., Farber, K., McCutcheon, M., Goodman, T. T., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.56 · Cited by 49
Yamamoto, T., Sawamura, M., Wada, F., Harada‐Shiba, M., & Obika, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.11.036 · Cited by 49
Ming, X., Sato, K., & Juliano, R. L. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.029 · Cited by 48
Self-citationAkhtar, S. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.518611 · Cited by 47
Unraveling the influence of endothelial cell density on VEGF-A signaling
Napione, L., Pavan, S., Veglio, A., Picco, A., Boffetta, G., Celani, A., Seano, G., Primo, L., Gamba, A., & Bussolino, F. (2012) · Blood · doi:10.1182/blood-2011-11-390666 · Cited by 46
Integrin Targeted Delivery of Gene Therapeutics
Juliano, R. L., Ming, X., Nakagawa, O., Xu, R., & Yoo, H. (2011) · Theranostics · doi:10.7150/thno/v01p0211 · Cited by 46
Self-citationNanotechnology for In vivo Targeted siRNA Delivery
Dahlman, J. E., Kauffman, K. J., Langer, R., & Anderson, D. G. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00003-1 · Cited by 45
Ohyama, A., Higashi, T., Motoyama, K., & Arima, H. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00545 · Cited by 44
Implications of Scavenger Receptors in the Safe Development of Nanotherapeutics
Shannahan, J. H., Bai, W., & Brown, J. M. (2015) · Receptors & Clinical Investigation · doi:10.14800/rci.811 · Cited by 43
Guanabenz (Wytensin™) selectively enhances uptake and efficacy of hydrophobically modified siRNAs
Osborn, M. F., Alterman, J. F., Nikan, M., Cao, H., Didiot, M. C., Hassler, M. R., Coles, A. H., & Khvorova, A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv942 · Cited by 42
Merkel, O. M., & Kissel, T. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.009 · Cited by 41
Protease-triggered siRNA delivery vehicles
Rozema, D. B., Blokhin, A. V., Wakefield, D. H., Benson, J. D., Carlson, J. C., Klein, J. J., Almeida, L., Nicholas, A. L., Hamilton, H., Chu, Q., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.012 · Cited by 40
Kang, H. M., Alam, M. R., Dixit, V., Fisher, M. H., & Juliano, R. L. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800270w · Cited by 39
Self-citationShabanpoor, F., McClorey, G., Saleh, A. F. A., Järver, P., Wood, M. J. A., & Gait, M. J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1256 · Cited by 39
Deciphering the Code of Innate Immunity Recognition of siRNAs
Sioud, M. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-547-7_2 · Cited by 39
Ma, D., Tian, S., Baryza, J. L., Luft, J. C., & DeSimone, J. M. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00054 · Cited by 36
Opriessnig, T., Patel, D., Wang, R., Halbur, P. G., Meng, X., Stein, D. A., & Zhang, Y. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.04.012 · Cited by 35
Cell Internalization SELEX: In Vitro Selection for Molecules That Internalize into Cells
Yan, A. C., & Levy, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-730-3_18 · Cited by 31
Warren, T. K., Whitehouse, C. A., Wells, J., Welch, L. S., Charleston, J. S., Heald, A., Nichols, D. K., Mattix, M. E., Palacios, G. F., Kugleman, J. R., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004456 · Cited by 31
Watanabe, A., Nakajima, M., Kasuya, T., Onishi, R., Kitade, N., Mayumi, K., Ikehara, T., & Kugimiya, A. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.230300 · Cited by 31
Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides
Weng, A., Manunta, M., Thakur, M., Gilabert‐Oriol, R., Tagalakis, A. D., Eddaoudi, A., Munye, M. M., Vink, C. A., Wiesner, B., Eichhorst, J., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.007 · Cited by 30
Niemann-Pick C1 Affects the Gene Delivery Efficacy of Degradable Polymeric Nanoparticles
Eltoukhy, A. A., Sahay, G., Cunningham, J. M., & Anderson, D. G. (2014) · ACS Nano · doi:10.1021/nn501630h · Cited by 30
Tuning up the right signal: chemical and genetic approaches to study GPCR functions
Giguère, P. M., Kroeze, W. K., & Roth, B. L. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.11.006 · Cited by 29
Kang, L., Wang, R. F., Yan, P., Liu, M., Zhang, C. L., Yu, M., Cui, Y. G., & Xiao, X. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069906 · Cited by 28
Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA
Wilner, S. E., & Levy, M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3197-2_18 · Cited by 28
Investigational therapies for the treatment of spinal muscular atrophy
Kaczmarek, A., Schneider, S. M., Wirth, B., & Rießland, M. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1038341 · Cited by 27
Enteral siRNA delivery technique for therapeutic gene silencing in the liver via the lymphatic route
Murakami, M., Nishina, K., Watanabe, C., Yoshida‐Tanaka, K., Piao, W., Kuwahara, H., Horikiri, Y., Miyata, K., Nishiyama, N., Kataoka, K., et al. (2015) · Scientific Reports · doi:10.1038/srep17035 · Cited by 27
Nakagawa, O., Ming, X., Carver, K. A., & Juliano, R. L. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400500h · Cited by 24
Self-citationEfficient siRNA Targeted Delivery into Cancer Cells by Gastrin-Releasing Peptides
Sioud, M., & Mobergslien, A. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300050j · Cited by 24
Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System
Hayashi, Y., Hatakeyama, H., Kajimoto, K., Hyodo, M., Akita, H., & Harashima, H. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00184 · Cited by 14
A Bifurcated Proteoglycan Binding Small Molecule Carrier for si RNA Delivery
Gooding, M., Adigbli, D. K., Chan, A. W. E., Melander, R. J., MacRobert, A. J., & Selwood, D. L. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12295 · Cited by 14
Braun, F., van den Brandt, J., Sören, T., Lange, S., Juliane, S., Gand, C., Przybylski, G. K., Schmoeckel, K., Bröker, B. M., Schmidt, C. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135444 · Cited by 12
Dendrimer conjugates for light-activated delivery of antisense oligonucleotides
Yuan, A., Hu, Y., & Ming, X. (2015) · RSC Advances · doi:10.1039/c5ra04091d · Cited by 9
Cited by
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
The chemical evolution of oligonucleotide therapies of clinical utility
Khvorova, A., & Watts, J. K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3765 · Cited by 1,216
Overcoming cellular barriers for RNA therapeutics
Dowdy, S. F. (2017) · Nature Biotechnology · doi:10.1038/nbt.3802 · Cited by 1,139
Non-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,032
Chemistry, structure and function of approved oligonucleotide therapeutics
Egli, M., & Manoharan, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad067 · Cited by 828
Metadata
- Authors
- Juliano, R. L.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-04-15
- Volume
- 44
- Issue
- 14
- Pages
- 6518-6548
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2336977304
- Cited by
- 854
- References
- 333
- FWCI
- 45.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.